Incubators

The Food and Drug Administration is forecasting a requirement for multiple incubators to replace malfunctioning equipment essential to microbiological analysis and pathogen testing. These incubators are critical to maintaining the integrity and accuracy of laboratory procedures, and their replacement is necessary to ensure continued operational effectiveness. The NAICS code 334516 indicates this procurement is related to laboratory and analytical instrument manufacturing, reflecting the technical specificity of the required equipment. The opportunity is posted on May 25, 2026, under the FDA’s acquisition portal and is intended for industry forecasting purposes rather than immediate solicitation. There is no set-aside classification specified, and place of performance details are not yet defined. Key contact information includes Hfp Acquisition Liaison at hfpacquisitions@fda.hhs.gov, while the Contracting Officer position is listed as to be determined. The forecast provides early visibility to potential vendors to prepare for future full and open competition, though no formal solicitation or bid deadlines have been issued.